2014. The Overexpression of ABCG2 Reduces the Efficacy of Volasertib (BI 6727) and GSK641364 in Human S1-M1-80 Colon Carcinoma Cells. Journal of Cancer Research Updates. 3, 2 (Apr. 2014),  108–116. DOI:https://doi.org/10.6000/1929-2279.2014.03.02.5.